Health care stocks were lower late Monday afternoon, with the NYSE Health Care Index down 0.3% and the Health Care Select Sector SPDR Fund (XLV) easing 0.1%.
The iShares Biotechnology ETF (IBB) added 0.1%.
In corporate news, Predictive Oncology (POAI) shares surged past 55% after it agreed to be acquired by Renovaro (RENB) in an all-stock deal. Renovaro shares popped 10%.
Citius Pharmaceuticals' (CTXR) majority-owned subsidiary Citius Oncology (CTOR) said it has retained Jefferies as a financial advisor to evaluate possible strategic alternatives. Citius Pharmaceuticals shares were down 2.3% and Citius Oncology jumped 18%.
Revance Therapeutics (RVNC) shares jumped 12%. The company has received a new buyout proposal from Teoxane Laboratories, offering $3.60 per share in cash, topping a bid from Crown Laboratories of $3.10 per share.
Regional Health Properties (RHE) and SunLink Health Systems (SSY) have agreed to merge in an all-stock deal. Regional shares soared 120% and SunLink surged 16%.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。